Sophie Delhomme

Sophie Delhomme is a seasoned professional in clinical project management with extensive experience in managing Phase I clinical trials and supporting various clinical programs. Currently serving as a Senior Clinical Project Manager at Teoxane Laboratories since November 2023, Sophie previously contributed to the Drugs for Neglected Diseases initiative (DNDi) from May 2013 to October 2023, managing early clinical development activities. Prior roles include Clinical Project Manager at Merck Serono, where talent was demonstrated in early clinical development and Phase I trials, as well as positions at Covance CLS, Amtech Chimie, and the Université de Geneve. Sophie holds a Post-Graduate Degree in Biomolecular Chemistry from Université Joseph Fourier (Grenoble I).